Debt (Narrative) (Detail) (USD $) In Thousands, unless otherwise specified	12 Months Ended			12 Months Ended						12 Months Ended			1 Months Ended
	Jun. 30, 2013	Jun. 30, 2011	Jun. 30, 2012	Jun. 30, 2013 Revolving Loans [Member]	Jun. 30, 2012 Revolving Loans [Member]	Jun. 30, 2013 Term Loan [Member] Installment	Jun. 30, 2012 Term Loan [Member]	Dec. 31, 2010 Term Loan [Member]	Dec. 31, 2010 Term Loan [Member] Rising Pharmaceuticals Inc. [Member]	Jun. 30, 2011 Foreign Line of Credit [Member]	Jun. 30, 2013 Foreign Line of Credit [Member]	Jun. 30, 2012 Foreign Line of Credit [Member]	Jun. 30, 2011 Mortgage Payable [Member]
Debt Instrument [Line Items]
Revolving loans, maximum amount				$ 40,000				$ 40,000
Revolving loans, expiration date				Dec. 31, 2015
Proceeds from bank loans	10,000	65,050		4,000
Bank loans, interest rate				2.06%		2.06%							5.92%
Proceeds from term loans used to finance business acquisition									40,000
Bank loans outstanding	28,500		42,000	4,000	11,000	24,500	31,000
Term loans, number of installments						20
Short term loans payable	11,714		6,713			7,500
Letters of credit	78		199
Lines of credit, remaining borrowing capacity											8,665	8,378
Lines of credit, interest rate										0.94%	5.00%	5.50%
Lines of credit, spread on variable rate basis										0.75%
Lines of credit, variable rate basis										LIBOR
Bank loans, unused borrowing capacity	44,587		37,179
Mortgage payable	$ 3,569		$ 3,765										$ 3,947
Mortgage payable, amortization period													20 years